Asbestosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

HTL0039732 in Participants With Advanced Solid Tumours
Conditions: Neoplasms; Prostatic Neoplasms, Castration-Resistant; Stomach Neoplasms; Esophageal Neoplasms; Head and Neck Neoplasms; Colorectal Neoplasms; Pancreatic Neoplasms; Lung Neoplasms; Urinary Bladder Neoplasms; Mesothelioma, Malignant; Uterine Cervical Ne oplasms; Kidney Neoplasms; Sarcoma; Pheochromocytomas Interventions: Drug: HTL0039732 Capsules; Drug: HTL0039732 Capsules and atezolizumab infusion Sponsors: Cancer Research UK; Heptares Therapeutics Limited Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials

Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
Condition: Mesothelioma Interventions: Drug: Durvalumab / tremelimumab; Drug: Platinum cisplatin or carboplatin and pemetrexed chemotherapy plus durvalumab/tremelimumab Sponsors: Baylor College of Medicine; Duke Cancer Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials